G-Def 6 Tablet contains Deflazacort 6mg, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions, including but not limited to rheumatoid arthritis, systemic lupus erythematosus, allergic reactions, and certain dermatological disorders. Deflazacort exerts its therapeutic effects by modulating the immune response and inhibiting the release of inflammatory mediators, thereby reducing inflammation, swelling, and tissue damage. The 6mg dosage provides an effective balance between efficacy and safety, minimizing corticosteroid-related adverse effects when used as prescribed. G-Def 6 Tablet should be administered under strict medical supervision, with dosage tailored according to the severity of the condition and patient response. It is essential to monitor patients for potential side effects such as hyperglycemia, hypertension, increased susceptibility to infections, osteoporosis, and adrenal suppression during prolonged therapy. Abrupt discontinuation should be avoided to prevent withdrawal symptoms and adrenal insufficiency. Caution is advised in patients with pre-existing conditions such as diabetes mellitus, hypertension, peptic ulcers, and psychiatric disorders. G-Def 6 Tablet is a valuable therapeutic agent for controlling inflammation and modulating immune function in a wide range of clinical scenarios.